Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Expert Opinion on Drug Safety|September 1, 2004
Safety and side effect profile of fluoxetineJoachim F WernickeFrontiers in Bioscience (Scholar Edition)|December 29, 2009
The placebo response in pain and depression: in search of a common pathwayJoachim F Wernicke, Melissa J OssannaJournal of Cardiovascular Electrophysiology|January 28, 2005
QT correction methods in children and adolescentsJoachim F Wernicke, Douglas Faries, Rebecca Breitung, et al.Drug Safety|October 20, 2005
Detecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methodsJoachim F Wernicke, Douglas Faries, Denái Milton, et al.Journal of Diabetes and Its Complications|September 5, 2008
Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditionsJoachim F Wernicke, Apurva Prakash, Daniel K Kajdasz, et al.Current Drug Safety|August 12, 2008
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sourcesIndiana Strombom, Joachim F Wernicke, John Seeger, et al.Expert Opinion on Drug Safety|November 1, 2005
Safety and adverse event profile of duloxetineJoachim F Wernicke, James Gahimer, Ilker Yalcin, et al.Journal of Women'S Health (2002)|October 17, 2007
Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trialsLesley M Arnold, Yili Lu Pritchett, Deborah N D'Souza, et al.Pain Medicine (Malden, Mass.)|November 4, 2005
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painJoel Raskin, Yili L Pritchett, Fujun Wang, et al.Pain|November 22, 2005
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderLesley M Arnold, Amy Rosen, Yili Lu Pritchett, et al.Pageof 2